agrees guidant deal
pharmaceutical johnson johnson agreed medical technology guidant
guidant producer equipment combats heart implant defibrillators pacemakers deal aimed offsetting johnson johnson reliance slowing drug mergers drug healthcare industries fragmented pressure cut johnson johnson facing patent expirations battling fierce generic demand defibrillators heart electric shock irregular heartbeat rhythm detected johnson johnson guidant wednesday closing antitrust regulators force overlapping stent operations stents tubes artery unblocked
